Martin A, Goldsmith N K, Friedman E W, Schwartz A E, Davies T F, Roman S H
Department of Medicine, Mount Sinai School of Medicine, New York, New York.
Autoimmunity. 1990;6(4):269-81. doi: 10.3109/08916939008998419.
In this study we have correlated peripheral T cell subset phenotypes with intrathyroidal lymphocyte accumulation in patients with autoimmune thyroid disease (Graves' and Hashimoto's disease). Our study utilized euthyroid family members for one of our control groups (n = 48) thus significantly limiting familial, but not disease-specific, influences on these T cell phenotypes. Our principal new observations were found only in patients with Graves' disease. As previously reported, there was a decrease in CD8+ (suppressor/cytotoxic) T cells in the peripheral blood of patients with untreated hyperthyroid Graves' disease (n = 27) (mean +/- SEM, 19 +/- 1.1% in patients compared with 25 +/- 1.2% in controls, p = 0.03), a finding not observed in treated, euthyroid Graves' disease patients or their relatives. However, the relative number of CD8+ T cells, assessed by CD4:CD8 ratios, was increased in the intrathyroidal T cell populations (n = 10), when compared to normal and patient peripheral blood. There were no consistent changes in total CD4+ (helper) T cells in the peripheral blood of patients with treated and untreated Graves' disease but a reduction in CD4+2H4+ (suppressor-inducer) T cells was seen in patients undergoing surgery for Graves' disease (13 +/- 6.9% compared with 39 +/- 3.4%). Again, however, this T cell subset was increased within the target organ of the same patients (41 +/- 5.9%). These data point to either a selective accumulation, or a specific "homing", of certain T cell subsets within the thyroid gland of patients with Graves' disease where T cell differentiation may be strongly influenced by antithyroid drug treatment and the local immune environment.
在本研究中,我们将自身免疫性甲状腺疾病(格雷夫斯病和桥本氏病)患者外周血T细胞亚群表型与甲状腺内淋巴细胞积聚情况进行了关联分析。我们的研究将甲状腺功能正常的家庭成员作为其中一个对照组(n = 48),从而显著限制了家族因素对这些T细胞表型的影响,但并未限制疾病特异性因素的影响。我们的主要新发现仅见于格雷夫斯病患者。如先前报道,未经治疗的甲状腺功能亢进格雷夫斯病患者(n = 27)外周血中CD8 +(抑制/细胞毒性)T细胞减少(平均值±标准误,患者为19±1.1%,对照组为25±1.2%,p = 0.03),这一发现未见于经治疗的甲状腺功能正常的格雷夫斯病患者或其亲属。然而,与正常人和患者外周血相比,通过CD4:CD8比值评估的甲状腺内T细胞群体中CD8 + T细胞的相对数量增加(n = 10)。接受治疗和未接受治疗的格雷夫斯病患者外周血中总CD4 +(辅助)T细胞没有一致的变化,但接受格雷夫斯病手术的患者中CD4 + 2H4 +(抑制诱导)T细胞减少(13±6.9%,而对照组为39±3.4%)。然而,同样地,该T细胞亚群在同一患者的靶器官内增加(41±5.9%)。这些数据表明,在格雷夫斯病患者的甲状腺内,某些T细胞亚群存在选择性积聚或特异性“归巢”现象,其中T细胞分化可能受到抗甲状腺药物治疗和局部免疫环境的强烈影响。